Bausch Health Companies Inc. expects US approval during the second half of 2020 of its application for the first preservative-free OTC eye drop containing ketotifen for the treatment of itching associated with allergic conjunctivitis.
Bausch submitted to the Food and Drug Administration an abbreviated new drug application for OTC use of preservative-free ketotifen, identified...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?